OPINION AND ORDER Plaintiffs Barbara Truss, Natalia Golson, Jack Kilgore, and Gabriela Pettibone bring this putative class action against defendants Bayer Healthcare Pharmaceuticals, Inc., Bayer Healthcare LLC, Beiersdorf, Inc., and Beiersdorf North America, Inc., arising out of defendants’ allegedly deceptive labeling of Coppertone Water Babies (SPF 50) sunscreen as hypoallergenic and free of oxybenzone, when in fact it contains benzophenone. Plaintiffs assert claims for deceptive practices under New York General Business Law Section 349 and the California Consumer Legal Remedies Act (the “deceptive practices claims”), false advertising under New York General Business Law Section 350 and the California False Advertising Law (the “false advertising claims”), unfair competition under the California Unfair Competition Law, and common law claims for breach of express warranty, breach of implied warranty of merchantability, and unjust enrichment (the “common law claims”). Now pending is defendants’ motion to dismiss the second amended complaint (“SAC”) under Rule 12(b)(6) and, solely with respect to plaintiffs’ request for injunctive relief, Rule 12(b)(1). (Doc. #48). For the following reasons, the motion is GRANTED. BACKGROUND For the purpose of the ruling on the motion, the Court accepts as true all well-pleaded allegations in the SAC and draws all reasonable inferences in plaintiffs’ favor, as summarized below. Defendants manufacture and distribute Coppertone Water Babies (SPF 50) sunscreen (the “Product”). Coppertone has been sold since 1944 and is a well-known sunscreen brand in the United States and abroad. Today, “thousands of retail locations throughout the United States” sell the Product. (SAC 21). Plaintiffs are citizens of California and New York who allegedly purchased the Product in 2021 and used it on themselves and their families. Plaintiffs allege the Product, although marketed as “hypoallergenic,” “dermatologically tested,” and “gentle on baby’s skin,” contains benzophenone, “a known mutagen, carcinogen, allergen, and endocrine disruptor that is not FDA approve[d] as an active ingredient in sunscreen products.” (SAC
1-2). Benzophenone is allegedly “a hazardous impurity and degradation product of octocrylene,” which is an active ingredient in the Product. (SAC 41). Plaintiffs determined the Product contains benzophenone by commissioning independent third-party testing. Plaintiffs allege benzophenone “is associated with a wide range of toxicities, including genotoxicity, carcinogenicity, and endocrine disruption” and is not hypoallergenic. (SAC
